Francesca Spagnoli is a Professor for Regenerative Medicine at King’s College London. After graduating from Medical School, Francesca obtained her Ph.D. in Developmental Genetics from the Pasteur Institute in Paris, France. She then conducted postdoctoral research at The Rockefeller University, New York, USA, with Dr A. Brivanlou. In 2008, she established her independent research group at the Max Delbrück Center in Berlin, Germany, where she initiated new lines of investigation on the control of pancreatic cell identity and lineage reprogramming strategies. Subsequently, in 2018 Francesca moved her group to the Centre for Stem Cells and Regenerative Medicine, King’s College London, UK. She has been the recipient of prestigious awards, including ERC Starting and ERC Proof-of-Concept grants, Wellcome Trust Investigator award, and EIC FET-Open consortium. She is currently the Director of the Wellcome Trust PhD Programme in ‘Advanced Therapies for Regenerative Medicine’ and the Coordinator of a multidisciplinary Type 1 Diabetes Grand Challenge research programme funded by Steve Morgan Foundation/JDRF/Diabetes UK to develop innovative bioengineering solution for diabetes cell therapy. The long-term goal of her research is to translate developmental concepts into new therapies.
